1. Association of high serum soluble interleukin 2 receptor levels with risk of adverse events in patients with cardiac sarcoidosis. (14th October 2021) Authors: Kobayashi, Y; Nagai, T; Hirata, K; Tsuneta, S; Kato, Y; Komoriyama, H; Kamiya, K; Konishi, T; Sato, T; Omote, K; Ohira, H; Kudoh, K; Konno, S; Anzai, T Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The role of right ventricular late gadolinium enhancement scoring by cardiac magnetic resonance imaging in cardiac sarcoidosis. (25th November 2020) Authors: Koyanagawa, K; Naya, M; Manabe, O; Furuya, S; Tsuneta, S; Ohira, H; Tsujino, I; Oyama-Manabe, N; Anzai, T Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗